Abstract:Inge Dhamanti, 1– 3 Auliya A Suwantika, 4– 6 Amirah Adlia, 7 Laura Navika Yamani, 8, 9 Fitri Yakub 10 1 Department of Health Policy and Administration, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia; 2 Center for Patient Safety Research, Universitas Airlangga, Surabaya, Indonesia; 3 School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia; 4 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia; 5 Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia; 6 Center for Health Technology Assessment, Universitas Padjadjaran, Bandung, Indonesia; 7 Department of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Bandung, Indonesia; 8 Division Epidemiology, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia; 9 Research Center on Global Emerging and Re-Emerging Infectious Diseases, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia; 10 Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Skudai, Malaysia Correspondence: Inge Dhamanti, Tel +62315920948, Email The COVID-19 pandemic had a severe global impact. A range of campaigns and activities, including vaccines, are being implemented to counteract this pandemic. Using observational data, the goal of this scoping review is to identify adverse events connected with COVID-19 vaccinations. We conduct a scoping study and searched three databases from the start of the COVID-19 pandemic in 2020 through June 2022. Based on our criteria and searched keywords, the review included eleven papers in total, with the majority of the studies being conducted in developed countries. The study populations varied and included general community populations, healthcare professionals, military forces, and patients with systemic lupus and cancer. This study includes vaccines from Pfizer-BioNTech, Oxford-AstraZeneca, Sinopharm, and Moderna. The COVID-19 vaccine-related adverse events were classified into three types: local side effects, systemic side effects, and other side effects such as allergies. The adverse reactions to COVID-19 vaccines are mild to moderate in severity, with no significant influence or interference in individual daily activities and no unique patterns in cause of death among vaccine-related deaths. According to the findings of these investigations, the COVID-19 vaccine is safe to administer and induces protection. It is vital to convey accurate information to the public about vaccination side effects, potential adverse responses, and the safety level of the vaccines supplied. Multiple strategies must be implemented at the individual, organizational, and population levels to eliminate vaccine hesitance. Future studies could investigate the vaccine's effect on people of various ages and medical conditions. Keywords: adverse effect, COVID-19 vaccines, vaccine reactions, vaccination impact COVID-19, which has been declared a global pandemic by WHO, has already infected over 38 million people and claimed at least one million lives since the virus first emerged in late 2019 from Wuhan, China. 1,2 The global infection detection rate was close to 10%, and it is estimated that 66% of people have been infected at least once as of May 2022. 3 Based on these findings, the world has been dealing with a devastating COVID-19 pandemic. A variety of campaigns and actions are being undertaken to combat this pandemic, beginning with the establishment of local lockdowns and mass testing. 4,5 Furthermore, as a new promising way, COVID-19 vaccine can be called hope to reduce the mortality rate of infected individuals and return to some forms of normal life. 6 The United States has approved the use of two COVID-19 vaccines, Pfizer-BioNTech and Moderna COVID-19 vaccines, both of which are to be administered in a two-dose sequence. Following Phase III clinical trials in ten countries worldwide, China and a few other countries approved the Sinopharm COVID-19 vaccine. 7 Because these vaccines were modeled using various processes and approaches, they differ in some aspects such as efficacy and storage conditions. 8 The side effects of the COVID-19 vaccine were reported by 50% to 90% of participants in randomized clinical trials of COVID-19 vaccines. 9 Another study conducted worldwide (US, Argentina, Brazil, South Africa, Germany, and Turkey) showed that more than 30% of participants had side effects. 10 Clinical trials conducted in Argentina, Brazil, Chile, Colombia, Mexico, Peru, South Afri -Abstract Truncated-

Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria

Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study

Adverse events following COVID-19 vaccination: A comprehensive analysis of spontaneous reporting data in Ghana

Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE—An Observational Study

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.

Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia

Safety and Immunogenicity of Fractional Doses of COVID-19 Vaccines among Nigerian Adults- A Randomised Non-Inferiority trial

Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study

COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria

Side effects associated with homogenous and heterogenous doses of Oxford–AstraZeneca vaccine among adults in Bangladesh: an observational study

Adverse events associated with AstraZeneca COVID-19 vaccine among adults in Greater Kampala, Uganda: a cross-sectional study

Factors influencing adverse events following COVID-19 vaccination

Safety Surveillance of Covishield Vaccine-Associated Adverse Events During the COVID-19 Pandemic: A Retrospective Longitudinal Study

COVID-19 vaccination hesitance and adverse effects among US adults: a longitudinal cohort study

Distinct Adverse Reactions to mRNA, Inactivated Virus, and Adenovirus Vector COVID-19 Vaccines: Insights from a Cohort Study on Atopic and Non-Atopic Subjects in Brazil

Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study

Factors influencing COVID-19 vaccine uptake among adults in Nigeria

Safety and Adverse Effects of the Coronavirus Disease 2019 Vaccine among the General Japanese Adult Population.

Evaluation of the Safety Profile of COVID-19 Vaccines: a Rapid Review

Adverse Reactions of COVID-19 Vaccines: A Scoping Review of Observational Studies